We have recently shown that chemical inhibition of SphK2 can reduce acute lymphoblastic leukemia (ALL) cell growth, induce cell death in vitro and extend the survival of mice bearing human ALL xenografts. This evidence concerns the gene SPHK2 and acute lymphoblastic leukemia.